Cresco Labs Reports $30 Million in Q1 Operating Cash Flow

LOS ANGELES- Cresco Labs Inc. reported $30 million in operating cash flow for the first quarter of 2025, reflecting its ongoing emphasis on cash generation and financial discipline. This figure follows a record $132 million in operating cash flow for the full year 2024, more than doubling the $59 million reported in 2023

The company’s Q1 2025 revenue was $166 million, with an adjusted gross profit of $82 million, representing a 49% margin. Adjusted EBITDA for the quarter stood at $36 million, yielding a 22% margin. Cresco Labs ended the quarter with $162 million in cash, its highest balance in three years

CEO Charlie Bachtell attributed the strong cash performance to measures such as limiting sales to wholesale accounts with credit risk and maintaining a disciplined approach to capital deployment. The company aims to support long-term value creation through strategic investments and margin expansion.

Analysts have noted Cresco Labs’ focus on optimizing its operations and product portfolio. Haywood Capital Markets analyst Neal Gilmer maintained a “Buy” rating on the company, citing its efforts to reduce operating costs and improve cash from operations .

Cresco Labs operates in eight U.S. states, with a significant presence in Illinois, Ohio, Pennsylvania, and Florida. The company continues to prioritize cash generation and balance sheet improvement over short-term revenue growth, positioning itself for sustainable expansion in the evolving cannabis market.